Skip to main content
Top
Published in: The Ultrasound Journal 1/2024

Open Access 01-12-2024 | Original article

Replacement of fluoroscopy by ultrasonography in the evaluation of hemidiaphragm function, an exploratory prospective study

Authors: Søren Helbo Skaarup, Peter Juhl-Olsen, Anne Sofie Grundahl, Brian Bridal Løgstrup

Published in: The Ultrasound Journal | Issue 1/2024

Login to get access

Abstract

Introduction

Dysfunction of the diaphragm may ultimately lead to respiratory insufficiency and compromise patient outcome. Evaluation of diaphragm function is cumbersome. Fluoroscopy has been the gold standard to measure diaphragmatic excursion. Ultrasonography can visualize diaphragm excursion and holds many advantages such as no radiation exposure, increased portability and accessibility. However, correlation between fluoroscopy and ultrasonography has never been studied. We aimed to compare fluoroscopic and ultrasound measures of diaphragm excursion to determine if ultrasonography can replace fluoroscopy.

Methods

We performed ultrasound and fluoroscopy simultaneously during sniff inspiration and at total inspiratory capacity in patients with chronic obstructive pulmonary disease, heart failure and in healthy volunteers. Cranio-caudal excursion was measured by fluoroscopy and compared directly to M-mode excursion, B-mode excursion, area change, resting thickness, thickening fraction and contraction velocity measured by ultrasonography.

Results

Forty-two participants were included. The Pearson correlation between M-mode and fluoroscopy excursion was 0.61. The slope was 0.9 (90%CI 0.76–1.04) in a regression analysis. Using the Bland–Altman method, the bias was − 0.39 cm (95% CI − 1.04–0.26), p = 0.24. The Pearson correlation between fluoroscopy and B-mode and area change ultrasonography was high; low for thickness and fraction. All correlations were lower during sniff inspiration compared with inspiratory capacity breathing.

Conclusion

Ultrasonography has an acceptable correlation and bias compared to fluoroscopy and can thus be used as the primary tool to evaluate diaphragm excursion.
Appendix
Available only for authorised users
Literature
7.
go back to reference Houston JG, Angus RM, Cowan MD et al (1994) Ultrasound assessment of normal hemidiaphragmatic movement: relation to inspiratory volume. Thorax 49:500–503CrossRefPubMedPubMedCentral Houston JG, Angus RM, Cowan MD et al (1994) Ultrasound assessment of normal hemidiaphragmatic movement: relation to inspiratory volume. Thorax 49:500–503CrossRefPubMedPubMedCentral
11.
go back to reference Gerscovich EO, Cronan M, McGahan JP et al (2001) Ultrasonographic evaluation of diaphragmatic motion. J Ultrasound Med 20:597–604CrossRefPubMed Gerscovich EO, Cronan M, McGahan JP et al (2001) Ultrasonographic evaluation of diaphragmatic motion. J Ultrasound Med 20:597–604CrossRefPubMed
Metadata
Title
Replacement of fluoroscopy by ultrasonography in the evaluation of hemidiaphragm function, an exploratory prospective study
Authors
Søren Helbo Skaarup
Peter Juhl-Olsen
Anne Sofie Grundahl
Brian Bridal Løgstrup
Publication date
01-12-2024
Publisher
Springer International Publishing
Published in
The Ultrasound Journal / Issue 1/2024
Electronic ISSN: 2524-8987
DOI
https://doi.org/10.1186/s13089-023-00355-0

Other articles of this Issue 1/2024

The Ultrasound Journal 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine